AR-R17779 HYDROCHLORIDE
中文名称 | AR-R17779 HYDROCHLORIDE |
---|---|
中文同义词 | 化合物 T21857;AR-R17779 盐酸盐 |
英文名称 | AR-R 17779 hydrochloride |
英文同义词 | AR-R 17779 hydrochloride, >=98%;(3S)-Spiro[1-azabicyclo[2.2.2]octane-3,5'-oxazolidine]-2'-one hydrochloride;AR-R17779 Hydrochloride >=97% (HPLC) |
CAS号 | 178419-42-6 |
分子式 | C9H15ClN2O2 |
分子量 | 218.68 |
EINECS号 | |
相关类别 | |
Mol文件 | 178419-42-6.mol |
结构式 |
AR-R17779 HYDROCHLORIDE 性质
储存条件 | -20°C |
---|---|
溶解度 | <10.93mg/ml,溶于 DMSO; <21.87mg/ml,在水中 |
形态 | 粉末 |
颜色 | 白色至米色 |
旋光性 (optical activity) | [α]/D -59 to -69°, c = 1.0 in methanol |
IC50: 92 nM (α7-nAChR)
AR-R17779 is 5-fold more potent and 35000-fold more selective than (-)-nicotine for the α7 nicotinic receptor.
AR-R17779 (200 nM; 24 h) inhibits the LPS-induced TNF production in macrophages.
AR-R17779 (1-5 mg/kg; i.p. twice a day for 7 d) ameliorates arthritis, reduces synovial inflammation, delays onset of disease and protects against joint destruction.
AR-R17779 (1-10 mg/kg; s.c. for 3 weeks) improves learning in two radial-arm maze tasks and reverses working memory impairment caused by fimbria-fornix sections in rats.
Animal Model: | Male DBA/1 mice (8-10 weeks) were subjected to unilateral cervical vagotomy or sham surgery, after which arthritis was induced with type II collagen |
Dosage: | 1, 2.5, 5 mg/kg |
Administration: | I.p. twice daily from day 20 until day 26 |
Result: |
Ameliorated arthritis and delayed onset of disease.
Reduced erosive disease, cartilage degradation and synovial inflammation. Reduced TNFα levels in plasma and synovial tissue. |